1 Community-Based Research with Substance Dependent Offenders Randall Brown MD, PhD Health Improvement & Research Partnerships Forum Madison, WI 9/15/2011.

Slides:



Advertisements
Similar presentations
Principles of Drug Addiction Treatment: What Works with Offenders?
Advertisements

Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Treatment of Substance Involved Offenders in Criminal Justice Settings – Challenges & Outcomes Igor Koutsenok, MD, MS Assistant Professor of Psychiatry,
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
Models of Evaluation of Addiction Treatment Outcome Post-Treatment vs. During Treatment Evaluation of Effectiveness.
Residential Community Supervision Programs
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Strategies for Drug-Abusing.
Alcohol Misuse: Criminal Justice Contexts & Outcomes National Infrastructure for Translating Research into Clinical Practice NIH-NIAAA 1R25AA Arlington,
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Principles of Drug Addiction Treatment: What Works with Offenders? Rita Dries July 2006.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse RESEARCH and TREATMENT Provide.
VA Programs for Justice-Involved Veterans
Treatment Of Medical, Psychiatric, and Substance Use Co-morbidities In People Infected With HIV Who Use Drugs Frederick L. Altice (US, Malaysia, Ukraine)
Comparative Effectiveness Research in the National Drug Abuse Treatment Clinical Trials Network (CTN) CDR Steven Sparenborg, Ph.D., Udi Ghitza, Ph.D.,
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
Recovery Housing and The National Drug Control Strategy David K. Mineta Deputy Director, Demand Reduction Office of National Drug Control Policy (ONDCP)
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Psychopharmacotherapy in Correctional Institutions Robert P. Schwartz, M.D. Friends Research Institute Supported by NIDA R01 DA (PI: Kinlock)
HIV and Behavioral Health: An Update from SAMHSA Elinore F. McCance-Katz, MD, PhD Chief Medical Officer Substance Abuse and Mental Health Services Administration.
Drug Court ♦The alternative to incarceration  History žHow and why the experiment evolved  Main Features of Drug Court žCooperation within the adversarial.
Recovery Oriented Systems of Care in Minnesota
Shaping HIV & Correctional Health Care: Research Questions Moving Forward Redonna K. Chandler, Ph.D. Division of Epidemiology, Services, and Prevention.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Responding to Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Taking drugs if you have ___ is BAD. Increased rates transmission Unprotected sex –Anal intercourse Group sex or multiple partners Internet partners Injection.
Ohio Justice Alliance for Community Corrections October 13, 2011.
Results of the Vivitrol Pilot in Los Angeles County Presented by: Desiree A. Crevecoeur-MacPhail, Ph.D. Research Psychologist, UCLA ISAP.
Drug Offender Reform Act Smarter Sentencing + Smarter Treatment = Better Outcomes and Safer Neighborhoods.
Presented by: Cary Heck, Ph.D. University of Wyoming
Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.
Addiction Treatment as HIV Prevention Charles P. O’Brien, MD, PhD David Metzger, PhD George E. Woody, MD University of Pennsylvania Treatment Research.
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
Adult Drug Courts: The Effect of Structural Differences on Program Retention Rates Natasha Williams, Ph.D., J.D., MPH Post Doctoral Fellow, Morgan State.
Addressing Substance Use Disorders Translating Science To Policy In The 2010 Drug Control Strategy.
TREATMENT COURTS Inns of Court Presentation By John Markson & Elliott Levine October 17, 2012.
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
Treatment is the Key: Addressing Drug Abuse in Criminal Justice Settings Redonna K. Chandler, Ph.D. Branch Chief Services Research Branch Division of Epidemiology,
Evidence-Based Reentry Practices in a Jail Setting
North Carolina TASC NC TASC Bridging Systems for Effective Offender Care Management.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
2011 SAMHSA/CSAT Drug Court Grantee Meeting. Kathleen Sebelius Secretary U.S. Department of Health & Human Services “At the Department of Health and.
Many impacts at many levels Drugs and Society. How much does it cost? According to the NIDA substance abuse costs the nation a half a trillion dollars.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Clinical Management of Substance Misuse Dave Marteau Prison Health
SARAH M. BAGLEY, MD ASSISTANT PROFESSOR OF MEDICINE AND PEDIATRICS BOSTON UNIVERSITY SCHOOL OF MEDICINE AMERSA ANNUAL CONFERENCE NOVEMBER 5, 2015 Overdose.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
Substance Abuse Treatment: An Alternative to Prison By Heather Apo-Ewers Communications 1010 November 10, 2013.
Prison population totals Walmsley, R. World Prison Population List, 2013 Slides from Seth J. Prins,
Cleveland Municipal Drug Court: SAMHSA CSAT Adult Treatment Drug Court Grant Dr. Margaret Baughman Madison Wheeler, BS Paul Tuschman, BA Begun.
Hill Update, Actions and Bills Debbie Plotnick, MSS, MLSP and Nathaniel Counts, J.D. Friday, February 19, 2016.
Jon D. Berg M.Ed., LCPC Public Health Advisor Center for Substance Abuse Treatment Substance Abuse Mental Health Services Administration U.S. Department.
Substance Abuse and Mental Health Services Administration Impact of Screening and Brief Intervention Grants in Seven States: Substance Use, Criminal Justice,
Detention to community (DTC): A family-based substance abuse, delinquency treatment and HIV prevention intervention for juvenile offenders Lead Center.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
DEPARTMENT OF VETERANS AFFAIRS. VISN 7 Footprint  Square Miles: 121,029  Veteran Enrollees: 568,506 (approximate as of FY13)  States: 3  Senators:
Performance Evaluation of Drug Courts Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction.
PURPOSE BACKGROUND RESULTS STUDY DESIGN & METHODS HIV Risk Behaviors Among Male Prisoners Participating in a Randomized Clinical Trial of Methadone Maintenance.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Promising Practices Guidelines for Residential Substance Abuse Treatment.
screening, brief intervention and referral to treatment
Integrating Care Through Partnerships – Missouri’s Experience
David Sottile, Anthony DeFulio, and Kenneth Silverman INTRODUCTION
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Nick Szubiak, MSW, LCSW Director, Clinical Excellence in Addictions
Annals of Research and Knowledge (ARK)
The Judicial Branch’s Response to the Opioid Crisis
Presentation transcript:

1 Community-Based Research with Substance Dependent Offenders Randall Brown MD, PhD Health Improvement & Research Partnerships Forum Madison, WI 9/15/2011 Funding: NIH-NIDA 1K23 DA017283; UW ICTR Pilot Award; UW DFM Small Grant

2 Overview Substance dependence Chronic illness Associated crime Criminal justice interventions Adjudication/incarceration ‘Therapeutic jurisprudence’ Our research Randomized trial: medication-assisted Tx in primary vs specialist setting Future directions

3 3 Addiction is a Treatable Brain Disease Meth Addict 2 Yrs Abstinence Meth Addict 1 Mo Abstinence Never Used Meth

4 Drug Use & Crime Arrests for drug-related offenses have increased ~ 300% since 1980 –(580k  1.7 million) Criminal justice system overwhelmed –Non-violent users & addicted Incarceration does not ↓ use 1.Crime in America: FBI Uniform Crime Reports Simpson DD. Addiction 2001.

5 “Therapeutic Jurisprudence” & Drug Court Treatment improves outcomes –Including criminal behavior Drug treatment court –Community-based treatment –Case management Treatment assignment/monitoring Urine screening –Court appearances Sanctions/rewards Patkar et al. J Add Diseas Belenko. CASA 2001.

6 Drug Court “Explosion” Operational drug court programs in the U.S Huddleston et al. Natl. Drug Court Inst

7 Drug Court Research (1) Program evaluations – ↓ crime & drug use 2 RCTs –Gottfredson et al 2003 Rearrest: 83% vs 66%, p < 0.05 –Marlowe et al 2003 Urine drug screens (no difference) Rearrest (no difference) Effect for high risk subgroup

8 Drug Court Research (2) Program evaluations –Aggregate statistics only –Time/resources of grantees Important covariates/potential confounders unexamined Scant research on ongoing drug use Brown RT. Translational Research. In press.

9 Drug Treatment Court (DTC) “Flow”

10 Medication-Assisted Treatments Opioid dependence –Methadone –Buprenorphine/naloxone Specialist facilities Office-based

11 Study: Treatment of Opioid- Dependent Offenders Opioid dependent offenders Community supervision + treatment Incarceration/traditional adjudication Specialist care + methadone + counseling Specialist care + buprenorphine + counseling Primary care + buprenorphine + counseling Addiction severity, opioid use, treatment retention, health status, HIV risk behaviors, quality of life, new crime 12 months

12 Sample GenderMale10 Female6 Age< > 352 Education< HS2 ≥ HS14

13 Early Opioid Use Outcomes

14 Results by Tx Group

15 Conclusions Treatment prevents drug use and complications Drug treatment courts are booming & probably work better than jail Treatment matching? –Medication-assisted treatment –Employment/education –“Cultural sensitivity” –Mental health & drug use

16 Future Directions Pilot OWI Court study –Injectable naltrexone Expansion of opioid dependence treatment “Specialist stablization study”